QLI

Qilian International Holding Group Limited

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

QLI price

Qilian International Holding Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment QLI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals QLI

Valuation

P/E

0.00

Sector 0.64

Industry -1.62

P/BV

0.00

Sector 1.77

Industry 1.14

P/Revenue (PSR)

Sector 1.46

Industry 1.97

EV/EBITDA

Sector -46.22

Industry -35.08

EV/EBIT

Sector -49.82

Industry -39.19

P/EBITDA

Sector -31.39

Industry -21.18

P/EBIT

Sector -34.71

Industry -22.73

P/Total Assets

Sector 0.80

Industry 0.66

P/Net Current Assets

Sector -24.72

Industry -64.12

P/Working Capital

Sector 2.45

Industry -2.19

EPS

0.02

Sector -0.72

Industry -1.29

BVPS

1.20

Sector 4.27

Industry 2.63

Efficiency

Gross Margin

0.00%

Sector 49.00%

Industry 48.42%

EBITDA Margin

Sector -236.77%

Industry -16,811,838.30%

EBIT Margin

0.00%

Sector -20.23%

Industry -26.90%

Net Profit Margins

0.00%

Sector -24.38%

Industry -28.94%

Asset Turnover

Sector 0.13

Industry 0.06

Profitability

ROE

1.46%

Sector -27.00%

Industry -38.34%

ROA

1.22%

Sector -25.58%

Industry -47.77%

ROIC

Sector -507.57%

Industry -794.26%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.92

Industry 2.55

Net Debt / EBITDA

Sector -21.38

Industry -8.23

Net Debt / EBIT

Sector -6.87

Industry -36.54

Net Debt / Equity

Sector -0.58

Industry -1.17

Gross Debt / Equity

Sector -0.73

Industry -0.54

Equity/Assets

0.83

Sector 0.45

Industry 0.52

Liabilities/Assets

0.13

Sector 0.49

Industry 0.46

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-20.89%

Sector -

Industry -

Fundamentals QLI

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Qilian International Holding Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$0.73

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
QLI Qilian International Holding Group Limited	$0.00	-	0.00%	0.00	0.00	1.46%	0.00%
LLY Eli Lilly and Compay	$1,421.92	76.10%	0.47%	46.01	31.51	86.09%	31.90%
SNY Sanofi	$44.62	-8.49%	3.96%	4.18	0.77	18.43%	14.25%
GSK GlaxoSmithKline PLC	$49.49	12.48%	3.62%	15.22	4.30	30.52%	14.54%
CRMD CorMedix Inc.	$6.01	-46.91%	0.00%	2.52	1.02	54.93%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$27.68	14.17%	0.00%	15.38	1.57	10.30%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$14.20	6.61%	0.59%	32.21	2.91	8.97%	10.14%
ENLV Enlivex Therapeutics Ltd.	$1.81	-99.30%	0.00%	0.02	0.01	126.17%	0.00%
JNJ Johnson & Johnson	$275.85	51.95%	1.92%	41.75	8.24	20.02%	16.20%
ISRG Intuitive Surgical Inc.	$439.18	-18.31%	0.00%	52.02	9.66	18.04%	25.64%
NVS Novartis AG	$162.89	36.33%	1.90%	30.66	8.26	24.60%	17.82%
TMO Thermo Fisher Scientific Inc.	$698.38	25.52%	0.26%	36.55	4.73	13.40%	14.97%
ABT Abbott Laboratories	$106.14	-12.36%	2.35%	32.98	0.00	-%	11.52%
MDT Medtronic PLC	$97.22	9.49%	2.94%	23.79	2.45	10.57%	13.93%
CVS CVS Health Corporation	$90.62	16.81%	3.70%	23.54	1.44	6.21%	1.18%
BSX Boston Scientific Corp.	$42.69	-57.44%	0.00%	16.22	0.00	-%	18.14%
TMDX TransMedics Group Inc.	$65.48	-51.25%	0.00%	14.93	4.37	36.28%	22.69%
IDXX IDEXX Laboratories Inc.	$563.27	-10.26%	0.00%	39.02	27.58	74.21%	25.03%
RMD ResMed Inc.	$234.54	-6.55%	1.05%	22.29	5.15	24.27%	26.94%
HCA HCA Healthcare Inc.	$479.56	3.09%	0.64%	15.46	-32.96	-307.62%	8.77%
DHR Danaher Corporation	$232.15	8.94%	0.65%	37.89	3.06	8.27%	16.91%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

QLI - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

2,542.36%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/24/2023	03/06/2023	0.25000000

ABOUT Qilian International Holding Group

Qilian International Holding Group Limited

Average Investor10 user rating

4.0 (0 people)

United States

7 years

Founded: 2019

2021

Time since IPO - 5 years

292

Employees

Qilian International Holding Group Limited (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $42.79 million.

The company employs approximately 292 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Qilian International Holding Group Limited reported $- in revenue, generating net income of $626.21 Thousand.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker QLI.

Market cap

Net worth

$42.79 million

$42,792,133.00

Assets

$51.26 million

$51,257,994.00

Total Shares Outstanding

35.75 million

35,750,000

Average Daily Trading Volume

$17.12 Thousand

$17,121.56

Sector

Health

Industry

Pharmaceutical Products

QLI

QLI revenue and profits

Financial Results QLI

DRAG THE FRAME TO SEE MORE DATA

QLI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$90.62 19,62% (12M)

P/E

23.54

3.70%

ROE

6.21%

P/BV

1.44

CI - Cigna

$298.72 24,98% (12M)

P/E

11.53

2.07%

ROE

16.51%

P/BV

1.85

CNC - Centene

$67.08 89,65% (12M)

P/E

-6.50

0.00%

ROE

-20.35%

P/BV

1.46

HUM - Humana

$412.17 49,80% (12M)

P/E

38.53

0.65%

ROE

6.81%

P/BV

2.56

SNY - Sanofi

$44.62 --8,31% (12M)

P/E

4.18

3.96%

ROE

18.43%

P/BV

0.77

JNJ - Johnson & Johnson

$275.85 49,36% (12M)

P/E

41.75

1.92%

ROE

20.02%

P/BV

8.24

LLY - Eli Lilly

$1,421.92 65,83% (12M)

P/E

46.01

0.47%

ROE

86.09%

P/BV

31.51

HCA - HCA Healthcare

$479.56 5,05% (12M)

P/E

15.46

0.64%

ROE

-307.62%

P/BV

-32.96